Acute Myeloblastic Leukaemia in Adult Patients: ESMO Clinical Practice Guidelines

Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi138-vi143.
Authors: M.F. Fey, C. Buske

This guideline covers diagnosis and pathology/molecular biology, risk assessment and prognostic factors including karyotype/cytogenetics, molecular genetics, co-morbidity and other host factors, providing treatment recommendations, summarising current achievements in personalised medicine, and elaborating on response evaluation and follow-up.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings